HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CBD Public Hearing Could Extend FDA's Hand Further For Help From Congress

Executive Summary

Among comments submitted to FDA's docket in advance of public hearing May 31, National Organization for the Reform of Marijuana Laws' suggestions perhaps point to path ahead for agency. "Regulations governing the production, sale, quality, and marketing of these products must take place far more expeditiously in order to protect consumer safety," the group says. FDA already appealed to Congress in its notice about docket and hearing, says attorney Coleen Klasmeier. "The notice is really a comment directed to Congress."

Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

RS148859

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel